“Everyday the HIV/AIDS pandemic continues to kill three times as many people than died during the terrorist attacks of September 11, 2001” (Elbe 2006, p.119). The Human Immunodeficiency Virus (HIV) weakens the immune system by destroying the cells that fight disease and infection. In the final stages of the HIV infection, it can lead to the acquired immunodeficiency syndrome (AIDS). Not all people who are diagnosed with HIV progress to acquiring AIDS, although once you have been diagnosed with the HIV infection, you have it for life. HIV/AIDS have claimed the lives of more than 39 million people globally since the discovery (World Health Organisation 2014) with a majority of these cases being in sub-Saharan Africa.
Acquired Immune Deficiency Syndrome (AIDS) caused by the Human Immunodeficiency Virus (HIV) is one of many infectious diseases that plague the world today. According to the 2007 AIDS epidemic update put out by The United Nations Joint Program on HIV/AIDS (UNIADS) there were approximately 2.1 million AIDS related deaths and 33.2 million people infected with HIV world wide (UNAIDS/WHO Working Group, 2007). Despite its abundant resources and its well-developed financial sectors, South Africa has the largest HIV infected population in the world with approximately 5.7 million of its 44 million citizens living with HIV/AIDS (Global Health Facts, 2007). These 5.7 million cases alone account for over 28% of
Nearly three decades ago, there was an increase in deaths of HIV in sub-Saharan Africa. Developing countries have experienced the greatest HIV/AIDS morbidity and mortality, with the highest prevalence rates recorded in young adults in sub-Saharan Africa. In South Africa over three million people are killed by this disease (Macfarlene3). After this epidemic spreaded in Africa and killed people it branched out to other countries in the world.
There are an immense amount of problems in Africa caused by the AIDS disease. Healthcare providers are available and located all over Africa. Even though they are available, they have only “enough medicine for long-term survival available for 30,000 Africans” (Copson, 3).
Human immunodeficiency virus (HIV)/AIDS is a pandemic problem affecting global health. At the end of 2015, 36.7 million people were living with HIV/AIDS globally. The rate of incidence is more prevalent in Sub-Saharan Africa with almost 1 in every 24 adults living with HIV/AIDS. In the united states, HIV/AIDS is a diversified health problem affecting all sexes, ages and races and involving the transmission of multiple risk behavior. However, with the introduction of various prevention programs and antiretroviral drugs, the incidence of HIV/AIDS has reduced.
The epidemic disease AIDS was discovered in the US in 1981. According the world health Organization (WHO) ‘’ Acquired immunodeficiency syndrome (AIDS) is a term which applies to the most advanced stages of HIV infection”. The outbreak of this HIV (Human Immunodeficiency Virus) affected women, men, and children from every single part of the world and resulted in fears and folk tale and the deaths of many. The World Health Organization (WHO) and the Joint United Nations Program on HIV/AIDS (UNAIDS) estimates 34.3 million people worldwide were living with HIV/AIDS at the end of 1999 and an estimated 15,000 people become infected each day. An epidemic
In the sub-Saharan Africa, the majority of the population suffers from HIV leading to AIDS. The culprits responsible for this epidemic include the lack of knowledge about the disease, disuse of condoms due to religious practices and the overall poor hygiene. If left untreated, the rampant surge of AIDS can terrribly impact the cost of their healthcare, the African economy and the welfare of the people. This implications justify immediately finding remedies to what ails the sub-Saharan population.
Since its identification approximately two decades ago, HIV has increasingly spread globally, surpassing expectations (1). The number of people living with HIV worldwide is estimated to be 36 million, with 20 million people having died from the disease, giving a total number of 56 million being infected (1). In 2000 alone, 5.3 million people were infected with HIV and there is potential for further spread. HIV infection rates vary all over the world with the highest rates in Sub-Saharan Africa (1). Responding to this epidemic has been a challenge as infection rates have increased worldwide despite tremendous public health efforts by nations (1). The identification of potential interventions to reduce the magnitude of the problem has
In 2014, 1.2 million people died from HIV and its related causes. In the same year, about 36.9 million people were living with HIV. Among these, 2 million were newly infected in 2014. The rate of infection has reduced by 35% between the years of 2000 and 2015. Between the same years, mortality due to HIV fell by 24%. The area with the most HIV/AIDS victims is Sub-Saharan Africa. In this region, 25.8 million people were living with HIV in 2014. The region also has 70% of the newly infected victims in the world. It is very unfortunate that more than 50% of people with HIV know that they have it. HIV testing efforts have improved with 150 million in 129 low and middle income counties getting tested. It was reported in 2015 that 15.8 million people were receiving antiretroviral therapy (World Health Organization,
In 2011 there were an estimated 23.5 million people living with HIV in Sub-Saharan Africa. 1 This rate has increased since 2009, when an estimated 22.5 million people were existing with Aids, as well as 2.3 million children. 2 In 2012, more than 1.1-million individuals were believed to have dies from AIDS-related
Introduction –HIV, Human immune deficiency virus which started in late mid 90s has already devastated many people causing great economic impact on their families, communities and health care systems. In USA the first HIV patient was diagnosed in 1981 after which disease spreads rapidly by which it affects nearly 1.2 million people as of now. As per US centre for disease control and prevention Out of 1.2 million
Although HIV is no longer the automatic death sentence it was in the 80’s, it remains a thorn even in our modern societies. For instance, HIV treatment is exponentially expensive, and can only be afforded by residents in developed countries. In fact, most third world nations are still in the 80’s as far as HIV treatment technology is concerned. Fatality rates particularly in Africa are astronomical to say the least (Rensburg 267). With prices, for
When it comes to HIV/AIDS, it is still today regarded as the most critical epidemic that affects a significant number of people in the world’s population. HIV statistics for the end of 2013 indicate that around 35 million people are currently living with HIV worldwide, 38 percent less than in 2001. In the same year, around 2.1 million people became infected with HIV and 1.5 million died of AIDS-related illnesses. HIV and AIDS are found in all parts of the world, however some areas are more affected than others (“Global HIV & AIDS Epidemic,” 2014).
Although ninety-five percent of people living with HIV/AIDS are in developing countries, the impact of this epidemic is global. In South Africa, where one in four adults are living with the disease, HIV/AIDS means almost certain death for those infected. In developed countries however, the introduction of antiretroviral drugs has meant HIV/AIDS is treated as a chronic condition rather than a killer disease. In developing countries like South Africa, the drugs that allow people to live with the disease elsewhere in the world, are simply too expensive for individuals and governments to afford at market price.
HIV is a virus that is spread almost all over the world. Although in some places health care isn’t as developed and therefore it spreads more in those regions. Sub-Saharan Africa holds more than 70%, 25 million, of all HIV positive people in the world. Second highest is Eastern Europe together with Central Asia with 1.3 million. It is spread over most of the world, including Asia and the Pacific, the Caribbean, Central and South America, North Africa and the Middle East and Western and Central Europe (“The Regional Picture”).